Biostatistics in Research: Making Sense of Biological Data

Biostatistics is the discipline that applies statistical reasoning to biological questions — from clinical drug trials to ecological surveys to genomic studies. This page covers what biostatistics actually does, how its core methods operate, where it appears in real research, and how researchers decide which tools to reach for. It matters because the difference between a genuine finding and a statistical artifact often comes down to whether the right method was used in the first place.

Definition and scope

A p-value below 0.05 does not mean a drug works. That misunderstanding has contributed to what the Nature journal network has called a "replication crisis," in which a substantial fraction of published biomedical findings fail to reproduce (Nature, "Reproducibility and replication of research," nature.com). Biostatistics is the set of tools designed to prevent exactly that kind of error — and to quantify how confident researchers can be in any given claim.

At its core, biostatistics addresses two problems that are unique to living systems. First, biological data is inherently variable — two mice from the same litter, raised identically, will not respond identically to a treatment. Second, direct measurement of entire populations is almost never possible, so researchers draw inferences from samples. Biostatistics provides the formal framework for moving from sample observations to population-level conclusions without overstating certainty.

The discipline spans experimental design (deciding how many subjects are needed before data collection begins), descriptive statistics (characterizing what was observed), inferential statistics (generalizing from the sample), and survival analysis (modeling time-to-event outcomes, such as disease recurrence). It sits at the intersection of foundational scientific reasoning and domain-specific biological knowledge — a statistician who doesn't understand cell biology will miss confounders; a biologist who doesn't understand statistics will misread their own results.

How it works

The engine running underneath most biostatistical analysis is probability theory — specifically, the idea that observed data can be modeled as one possible outcome drawn from a distribution of outcomes. From that foundation, the field builds upward:

1. Hypothesis formulation — A null hypothesis (H₀) states that no effect exists; the alternative hypothesis (H₁) states that one does. The researcher never "proves" H₁; the test either produces sufficient evidence against H₀ or it doesn't.
2. Sample size calculation — Before data collection, a power analysis determines the minimum number of subjects needed to detect an effect of a specified size at a given significance level. A study powered at 80% has a 20% chance of missing a real effect (a Type II error).
3. Data collection and randomization — Random assignment to treatment groups controls for unknown confounders. Without randomization, correlation and causation become difficult to disentangle.
4. Statistical testing — The choice of test depends on data type, distribution, and study design. A t-test compares two group means; ANOVA extends this to three or more groups; logistic regression models binary outcomes; Cox proportional hazards models survival data.
5. Interpretation — Results are reported with effect sizes and confidence intervals, not p-values alone. A 95% confidence interval that spans zero suggests the effect is not statistically distinguishable from noise.

The American Statistical Association's 2016 statement on p-values (ASA Statement on Statistical Significance and P-Values) explicitly warned that a p-value does not measure the probability that the null hypothesis is true — a point still widely misunderstood in published literature.

Common scenarios

Biostatistics appears wherever biological data gets collected and interpreted:

• Clinical trials — Phase III trials typically require hundreds to thousands of participants to detect clinically meaningful differences between treatment and placebo arms. The FDA's guidance on adaptive trial designs (FDA Adaptive Designs for Clinical Trials, fda.gov) relies heavily on sequential biostatistical methods.
• Epidemiology — Relative risk and odds ratios quantify how strongly an exposure (smoking, diet, occupational hazard) is associated with disease incidence in a population.
• Genomics — A genome-wide association study (GWAS) might test 1 million or more genetic variants simultaneously, requiring correction methods like the Bonferroni correction or false discovery rate (FDR) to control for the sheer number of comparisons being made.
• Ecology — Population biologists use mark-recapture studies and Bayesian occupancy models to estimate species abundance without counting every individual.

Decision boundaries

Choosing a biostatistical method is not a mechanical lookup — it requires matching tool to context. The central distinctions worth understanding:

Parametric vs. non-parametric tests. Parametric tests (t-test, ANOVA) assume the data follows a specific distribution, usually normal. Non-parametric equivalents (Mann-Whitney U, Kruskal-Wallis) make no such assumption and are appropriate when sample sizes are small or distributions are clearly skewed. The tradeoff is statistical power: parametric tests extract more information from the same data when their assumptions hold.

Frequentist vs. Bayesian approaches. Frequentist statistics — dominant in most published biomedical research — interprets probability as the long-run frequency of events. Bayesian statistics incorporates prior knowledge and produces a probability distribution over possible effect sizes, not a binary accept/reject decision. The bioscience research landscape increasingly sees Bayesian methods applied in genomics and epidemiological modeling, particularly where prior data is rich and sample sizes are limited.

Correlation vs. causation. A Pearson correlation coefficient of 0.85 between two biomarkers is striking. It is not, on its own, evidence that one causes the other. Establishing causation requires experimental manipulation, longitudinal design, or causal inference frameworks such as directed acyclic graphs (DAGs).

The practical upshot is that method choice made before data collection shapes what can be claimed afterward. A study designed for correlation cannot be post-hoc reanalyzed into causation — not honestly, at any rate.